Top 10 Companies in the Global Albendazole API Market (2026): Market Leaders Powering Global Health

MARKET INSIGHTS

Global Albendazole API market size was valued at USD 156.8 million in 2024. The market is projected to grow from USD 168.3 million in 2025 to USD 265.7 million by 2032, exhibiting a CAGR of 6.7% during the forecast period.

Albendazole API is a broad‑spectrum anthelmintic active pharmaceutical ingredient used to treat parasitic worm infections. As a benzimidazole carbamate drug substance, it works by inhibiting microtubule formation in parasites, effectively treating conditions like neurocysticercosis, hydatid disease, and various intestinal worm infections. The API is manufactured in different purity grades (98% and 99%) for formulation into tablets, capsules, and other dosage forms.

Market growth is primarily driven by increasing parasitic infection prevalence in tropical regions, government deworming initiatives, and expanding pharmaceutical production in emerging economies. While developed markets show steady demand, Asia‑Pacific dominates production with China accounting for over 60% of global API supply. Recent quality control enhancements by manufacturers and regulatory approvals for new formulations are creating additional growth opportunities in this space.

Global Albendazole API Market – View in Detailed Research Report

---

🔟 10. Hubei Keyi Pharmaceutical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: 99% purity Albendazole API for generic and branded formulations

Hubei Keyi has positioned itself as a reliable supplier for national deworming programs and private pharmaceutical manufacturers. Its production line meets WHO‑GMP and EU‑GMP standards, ensuring consistent quality for both domestic and export markets.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing facilities
• Adoption of continuous manufacturing to reduce waste and improve yield
• Collaboration with academic institutions for research on resistance mitigation

---

🧑‍🔬 9. Supharma Chem

Headquarters: Bengaluru, India
Key Offering: 98% and 99% purity Albendazole API for domestic and export markets

Supharma Chem has leveraged its strong R&D capabilities to develop cost‑effective synthesis routes, enabling competitive pricing while maintaining high quality for global partners.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management system
• Use of green chemistry principles in raw material sourcing
• Strategic partnerships with Indian pharmaceutical companies for local distribution

---

💡 8. K. A. Malle Pharmaceuticals

Headquarters: Mumbai, India
Key Offering: 99% purity Albendazole API for generic manufacturers

K. A. Malle focuses on scaling production to meet the growing demand from both Indian and international markets, with a strong emphasis on regulatory compliance.

Sustainability & Growth Initiatives:

• ISO 9001 certification for quality management
• Investment in waste‑to‑energy projects within the plant
• Engagement in public‑private partnerships for rural health programs

---

🛠️ 7. Manus Aktteva Biopharma

Headquarters: New Delhi, India
Key Offering: 99% purity Albendazole API for generic and specialty formulations

Manus Aktteva has built a robust supply chain that supports rapid response to global health emergencies, ensuring uninterrupted supply for mass drug administration initiatives.

Sustainability & Growth Initiatives:

• Carbon‑neutral production targets by 2035
• Adoption of digital twins for process optimization
• Collaboration with international NGOs for disease‑control programs

---

⚙️ 6. TEVA (Zhejiang Wanma Synthetic Medicine)

Headquarters: Shanghai, China
Key Offering: 99% purity Albendazole API for global generic manufacturers

TEVA’s Chinese subsidiary has invested heavily in process optimization, achieving significant cost reductions while maintaining compliance with WHO‑GMP and EU‑GMP standards.

Sustainability & Growth Initiatives:

• Investment of USD 12 million in continuous manufacturing infrastructure
• Implementation of advanced analytics for real‑time quality control
• Strategic alliances with local universities for talent development

---

🏭 5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: 99% purity Albendazole API for both domestic and export markets

With a 40% increase in annual capacity in 2023, Zhejiang Jiuzhou has positioned itself as a key supplier for WHO‑prequalified products.

Sustainability & Growth Initiatives:

• Expansion of intermediate production facilities to reduce lead times
• Adoption of ISO 45001 occupational health and safety standards
• Collaboration with Chinese Ministry of Health for national deworming programs

---

🔬 4. Changzhou Jialing Pharmaceutical Co., Ltd.

Headquarters: Changzhou, China
Key Offering: 98% and 99% purity Albendazole API for generic manufacturers

Changzhou Jialing’s cost‑competitive synthesis technology has enabled it to capture a significant share of the African and Southeast Asian markets.

Sustainability & Growth Initiatives:

• Implementation of green chemistry protocols to reduce hazardous waste
• Participation in regional capacity‑building programs for local manufacturers
• Use of renewable energy sources for plant operations

---

📈 3. Hubei Zhongjia Synthetic Pharmaceutical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: 99% purity Albendazole API for global generic and branded markets

Hubei Zhongjia’s advanced chemical synthesis processes and strict quality controls have earned it a reputation for reliability among multinational pharmaceutical companies.

Sustainability & Growth Initiatives:

• ISO 14001 environmental management system implementation
• Investment in waste‑recycling technologies for by‑products
• Strategic partnerships with African distributors for market expansion

---

🌏 2. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

Headquarters: Xi’an, China
Key Offering: 99% purity Albendazole API for generic and branded formulations

With a vertically integrated manufacturing network and a 18% share of global production capacity in 2024, Shaanxi Hanjiang is a market leader, supplying both domestic and international customers.

Sustainability & Growth Initiatives:

• Comprehensive quality assurance program meeting WHO‑GMP, EU‑GMP, and FDA standards
• Investment in renewable energy to power production facilities
• Collaboration with global health agencies for mass drug administration

---

🏆 1. Hubei Xingyinhe Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: 99% purity Albendazole API for generic manufacturers and specialty markets

Hubei Xingyinhe has become a strategic partner for many global pharmaceutical companies, offering high‑quality API at competitive pricing and reliable delivery schedules.

Sustainability & Growth Initiatives:

• ISO 9001 certification for quality management
• Adoption of continuous manufacturing to improve yield and reduce waste
• Participation in international trade agreements to streamline export processes

---

Download FREE Sample Report: Global Albendazole API Market – View in Detailed Research Report

Get Full Report Here: Global Albendazole API Market – View in Detailed Research Report

🌍 Outlook: The Future of Albendazole API is Driven by Global Health Initiatives

The Albendazole API market is set to experience sustained growth driven by expanding deworming programs, rising prevalence of parasitic infections in emerging economies, and increasing demand for generic anthelmintic formulations. The sector is poised for further expansion as regulatory harmonization and investment in continuous manufacturing technologies enhance production efficiency and quality.

📈 Future Trends Shaping the Market

• Growth of combination therapies pairing Albendazole with other antiparasitic agents to broaden therapeutic indications.
• Expansion of veterinary applications, particularly in livestock and companion animal segments.
• Vertical integration strategies adopted by key manufacturers to secure raw materials and improve margins.
• Adoption of digital twins and advanced analytics for real‑time quality control and process optimization.
• Increased focus on sustainability, including renewable energy use and waste reduction across the supply chain.